• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性病毒性肝炎、酒精中毒或肝硬化患者患肝癌和胆管癌的风险。

The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis.

作者信息

Kuper H, Ye W, Broomé U, Romelsjö A, Mucci L A, Ekbom A, Adami H O, Trichopoulos D, Nyrén O

机构信息

Department of Epidemiology and Public Health, University College London, London, UK.

出版信息

Hepatology. 2001 Oct;34(4 Pt 1):714-8. doi: 10.1053/jhep.2001.28233.

DOI:10.1053/jhep.2001.28233
PMID:11584367
Abstract

No prospective study has analyzed simultaneously chronic viral hepatitis and alcoholism as risk factors for liver carcinogenesis, while taking into consideration the role of cirrhosis. Nor has the risk for hepatocellular carcinoma among patients with chronic viral hepatitis been prospectively evaluated in a low-risk Western population. Last, the relationship between hepatocellular carcinoma risk factors and bile duct cancer remains to be clarified. We analyzed prospectively the risk for primary liver and extrahepatic biliary tract cancer among 186,395 patients hospitalized with either chronic viral hepatitis, alcoholism, cirrhosis, or any combination of these conditions through linkages between national Swedish registers. Compared with the general population, the relative risk of hepatocellular carcinoma was 34.4 for chronic viral hepatitis alone, 2.4 for alcoholism alone, and 40.7 for cirrhosis alone. Among patients with combinations of these risk conditions, the relative risk of hepatocellular carcinoma was 27.3 for chronic viral hepatitis and alcoholism, 118.5 for chronic viral hepatitis and cirrhosis, 22.4 for alcoholism and cirrhosis, and 171.4 for all 3 conditions. We found limited evidence for an excess risk of intrahepatic, but not for extrahepatic, biliary duct cancer. Cirrhosis amplifies the risk of hepatocellular carcinoma among patients with chronic viral hepatitis, but it is not a prerequisite for liver carcinogenesis. In contrast, cirrhosis may be a necessary intermediate for the development of hepatocellular carcinoma among alcoholics.

摘要

尚无前瞻性研究同时分析慢性病毒性肝炎和酗酒作为肝癌发生风险因素的情况,同时考虑肝硬化的作用。在低风险的西方人群中,也没有对慢性病毒性肝炎患者发生肝细胞癌的风险进行前瞻性评估。最后,肝癌风险因素与胆管癌之间的关系仍有待阐明。我们通过瑞典国家登记系统之间的关联,对186,395例因慢性病毒性肝炎、酗酒、肝硬化或这些情况的任何组合而住院的患者发生原发性肝癌和肝外胆管癌的风险进行了前瞻性分析。与普通人群相比,仅慢性病毒性肝炎患者发生肝细胞癌的相对风险为34.4,仅酗酒患者为2.4,仅肝硬化患者为40.7。在这些风险状况组合的患者中,慢性病毒性肝炎和酗酒患者发生肝细胞癌的相对风险为27.3,慢性病毒性肝炎和肝硬化患者为118.5,酗酒和肝硬化患者为22.4,三种情况并存的患者为171.4。我们发现肝内胆管癌存在额外风险的证据有限,而肝外胆管癌则没有。肝硬化会增加慢性病毒性肝炎患者发生肝细胞癌的风险,但它不是肝癌发生的先决条件。相比之下,肝硬化可能是酗酒者发生肝细胞癌的必要中间环节。

相似文献

1
The risk of liver and bile duct cancer in patients with chronic viral hepatitis, alcoholism, or cirrhosis.慢性病毒性肝炎、酒精中毒或肝硬化患者患肝癌和胆管癌的风险。
Hepatology. 2001 Oct;34(4 Pt 1):714-8. doi: 10.1053/jhep.2001.28233.
2
Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.肝硬化患者与非肝硬化患者肝细胞癌的危险因素分析:一项对213例来自印度的肝细胞癌患者的病例对照研究。
J Gastroenterol Hepatol. 2007 Jul;22(7):1104-11. doi: 10.1111/j.1440-1746.2007.04908.x. Epub 2007 Jun 7.
3
Precursor lesions for liver cancer in humans.人类肝癌的癌前病变。
Cancer Res. 1976 Jul;36(7 PT 2):2579-83.
4
A statistical model predicting high hepatocyte proliferation index and the risk of developing hepatocellular carcinoma in patients with hepatitis C virus-related cirrhosis.一种预测丙型肝炎病毒相关性肝硬化患者高肝细胞增殖指数及发生肝细胞癌风险的统计模型。
Aliment Pharmacol Ther. 2006 Jul 1;24(1):129-36. doi: 10.1111/j.1365-2036.2006.02955.x.
5
[Hepatocellular carcinoma and cholangiocarcinoma--different prognosis, pathogenesis and therapy].[肝细胞癌和胆管癌——不同的预后、发病机制及治疗]
Zentralbl Chir. 2007 Aug;132(4):300-5. doi: 10.1055/s-2007-981195.
6
Bile duct dysplasia in the setting of chronic hepatitis C and alcohol cirrhosis.慢性丙型肝炎和酒精性肝硬化背景下的胆管发育异常。
Am J Surg Pathol. 2007 Sep;31(9):1410-3. doi: 10.1097/PAS.0b013e318053d122.
7
Clinical study on etiologic aspects of primary hepatocellular carcinoma.原发性肝细胞癌病因学方面的临床研究
Tokai J Exp Clin Med. 1982 Jul;7(4):435-43.
8
Clinical and pathological factors associated with the development of hepatocellular carcinoma in patients with hepatitis virus-related cirrhosis: a long-term follow-up study.与肝炎病毒相关肝硬化患者肝细胞癌发生相关的临床和病理因素:一项长期随访研究
Clin Oncol (R Coll Radiol). 2007 Apr;19(3):197-203. doi: 10.1016/j.clon.2006.12.005. Epub 2007 Jan 18.
9
Colchicine delays the development of hepatocellular carcinoma in patients with hepatitis virus-related liver cirrhosis.秋水仙碱可延缓肝炎病毒相关性肝硬化患者肝细胞癌的发展。
Cancer. 2006 Oct 15;107(8):1852-8. doi: 10.1002/cncr.22198.
10
[Hepatic carcinogenesis: prevalent role of hepatitis C virus?].[肝癌发生:丙型肝炎病毒的普遍作用?]
Gastroenterol Clin Biol. 1994;18(4):394-6.

引用本文的文献

1
Alcohol-associated liver disease.酒精相关性肝病。
J Clin Invest. 2024 Feb 1;134(3):e176345. doi: 10.1172/JCI176345.
2
A Single-Step Immunocapture Assay to Quantify HCC Exosomes Using the Highly Sensitive Fluorescence Nanoparticle-Tracking Analysis.一种使用高灵敏度荧光纳米颗粒跟踪分析定量检测肝癌外泌体的单步免疫捕获测定法。
J Hepatocell Carcinoma. 2023 Nov 2;10:1935-1954. doi: 10.2147/JHC.S423043. eCollection 2023.
3
Comparison of Risk Factors for Cholangiocarcinoma and Hepatocellular Carcinoma: A Prospective Cohort Study in Korean Adults.
胆管癌和肝细胞癌危险因素的比较:一项针对韩国成年人的前瞻性队列研究。
Cancers (Basel). 2022 Mar 28;14(7):1709. doi: 10.3390/cancers14071709.
4
Statin and the risk of hepatocellular carcinoma in patients with hepatitis B virus or hepatitis C virus infection: a meta-analysis.他汀类药物与乙型肝炎病毒或丙型肝炎病毒感染患者肝细胞癌风险的关系:一项荟萃分析。
BMC Gastroenterol. 2020 Apr 9;20(1):98. doi: 10.1186/s12876-020-01222-1.
5
Diagnostic Sensitivity of NLR and PLR in Early Diagnosis of Gastric Cancer.中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值在胃癌早期诊断中的诊断灵敏度。
J Immunol Res. 2020 Mar 7;2020:9146042. doi: 10.1155/2020/9146042. eCollection 2020.
6
Prognostic subclass of intrahepatic cholangiocarcinoma by integrative molecular-clinical analysis and potential targeted approach.基于整合分子-临床分析的肝内胆管癌预后亚类及潜在的靶向治疗方法。
Hepatol Int. 2019 Jul;13(4):490-500. doi: 10.1007/s12072-019-09954-3. Epub 2019 Jun 18.
7
MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1.微小RNA-370通过靶向GUCD1调控肝细胞癌的上皮-间质转化、迁移、侵袭及预后
Yonsei Med J. 2019 Mar;60(3):267-276. doi: 10.3349/ymj.2019.60.3.267.
8
Liver Transplantation for Alcoholic Liver Disease and Hepatocellular Carcinoma.酒精性肝病和肝细胞癌的肝移植
Cancers (Basel). 2018 Feb 9;10(2):46. doi: 10.3390/cancers10020046.
9
HOXC6 predicts invasion and poor survival in hepatocellular carcinoma by driving epithelial-mesenchymal transition.HOXC6通过驱动上皮-间质转化来预测肝细胞癌的侵袭性和不良预后。
Aging (Albany NY). 2018 Jan 15;10(1):115-130. doi: 10.18632/aging.101363.
10
The role of thiazolidinediones in hepatocellular carcinoma risk reduction: a population-based cohort study in Taiwan.噻唑烷二酮类药物在降低肝细胞癌风险中的作用:一项基于台湾人群的队列研究。
Am J Cancer Res. 2017 Jul 1;7(7):1606-1616. eCollection 2017.